Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 321

1.

Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study.

Tazi A, Lorillon G, Haroche J, Neel A, Dominique S, Aouba A, Bouaziz JD, de Margerie-Melon C, Bugnet E, Cottin V, Comont T, Lavigne C, Kahn JE, Donadieu J, Chevret S.

Orphanet J Rare Dis. 2017 May 22;12(1):95. doi: 10.1186/s13023-017-0651-z.

2.

Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis.

Juge PA, Borie R, Kannengiesser C, Gazal S, Revy P, Wemeau-Stervinou L, Debray MP, Ottaviani S, Marchand-Adam S, Nathan N, Thabut G, Richez C, Nunes H, Callebaut I, Justet A, Leulliot N, Bonnefond A, Salgado D, Richette P, Desvignes JP, Lioté H, Froguel P, Allanore Y, Sand O, Dromer C, Flipo RM, Clément A, Béroud C, Sibilia J, Coustet B, Cottin V, Boissier MC, Wallaert B, Schaeverbeke T, Dastot le Moal F, Frazier A, Ménard C, Soubrier M, Saidenberg N, Valeyre D, Amselem S; FREX consortium., Boileau C, Crestani B, Dieudé P.

Eur Respir J. 2017 May 11;49(5). pii: 1602314. doi: 10.1183/13993003.02314-2016. Print 2017 May.

PMID:
28495692
3.

Pulmonary Vein Varices Are Syndromic Features in Turner Syndrome.

Nasser M, Revel D, Thibault H, Khouatra C, Cottin V.

Respiration. 2017 May 3. doi: 10.1159/000473883. [Epub ahead of print] No abstract available.

PMID:
28463845
4.

The challenge of criteria for interstitial pneumonia with autoimmune features.

Ahmad K, Cottin V.

Respir Med. 2017 Jun;127:67. doi: 10.1016/j.rmed.2017.04.003. Epub 2017 Apr 6. No abstract available.

PMID:
28416271
5.

A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease: An International Working Group Perspective.

Ryerson CJ, Corte TJ, Lee JS, Richeldi L, Walsh SLF, Myers JL, Behr J, Cottin V, Danoff SK, Flaherty KR, Lederer DJ, Lynch DA, Martinez FJ, Raghu G, Travis WD, Udwadia Z, Wells AU, Collard HR.

Am J Respir Crit Care Med. 2017 Apr 17. doi: 10.1164/rccm.201702-0400PP. [Epub ahead of print]

PMID:
28414524
6.

Reply to Official ATS/JRS Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management.

McCormack FX, Gupta N, Finlay G, Young LR, Johnson S, Cottin V, Wilson K, Moss J.

Am J Respir Crit Care Med. 2017 Mar 13. doi: 10.1164/rccm.201702-0417LE. [Epub ahead of print] No abstract available.

PMID:
28288285
7.

The yin and yang of idiopathic pulmonary fibrosis.

Kreuter M, Cottin V.

Eur Respir J. 2017 Feb 23;49(2). pii: 1602316. doi: 10.1183/13993003.02316-2016. Print 2017 Feb. No abstract available.

PMID:
28232416
8.

Interstitial pneumonia with autoimmune features: Clinical, radiologic, and histological characteristics and outcome in a series of 57 patients.

Ahmad K, Barba T, Gamondes D, Ginoux M, Khouatra C, Spagnolo P, Strek M, Thivolet-Béjui F, Traclet J, Cottin V.

Respir Med. 2017 Feb;123:56-62. doi: 10.1016/j.rmed.2016.10.017. Epub 2016 Oct 31.

PMID:
28137497
9.

Burden of Idiopathic Pulmonary Fibrosis Progression: A 5-Year Longitudinal Follow-Up Study.

Cottin V, Schmidt A, Catella L, Porte F, Fernandez-Montoya C, Le Lay K, Bénard S.

PLoS One. 2017 Jan 18;12(1):e0166462. doi: 10.1371/journal.pone.0166462. eCollection 2017.

10.

TuberOus SClerosis registry to increase disease Awareness (TOSCA) - baseline data on 2093 patients.

Kingswood JC, d'Augères GB, Belousova E, Ferreira JC, Carter T, Castellana R, Cottin V, Curatolo P, Dahlin M, de Vries PJ, Feucht M, Fladrowski C, Gislimberti G, Hertzberg C, Jozwiak S, Lawson JA, Macaya A, Nabbout R, O'Callaghan F, Benedik MP, Qin J, Marques R, Sander V, Sauter M, Takahashi Y, Touraine R, Youroukos S, Zonnenberg B, Jansen AC; TOSCA consortium and TOSCA investigators..

Orphanet J Rare Dis. 2017 Jan 5;12(1):2. doi: 10.1186/s13023-016-0553-5.

11.

Translation and validation of the King's Brief Interstitial Lung Disease (K-BILD) questionnaire in French, Italian, Swedish, and Dutch.

Wapenaar M, Patel AS, Birring SS, Domburg RTV, Bakker EW, Vindigni V, Sköld CM, Cottin V, Vancheri C, Wijsenbeek MS.

Chron Respir Dis. 2017 May;14(2):140-150. doi: 10.1177/1479972316674425. Epub 2016 Dec 26.

PMID:
28019103
12.

Genetics of idiopathic pulmonary fibrosis: from mechanistic pathways to personalised medicine.

Spagnolo P, Cottin V.

J Med Genet. 2017 Feb;54(2):93-99. doi: 10.1136/jmedgenet-2016-103973. Epub 2016 Dec 23. Review.

PMID:
28011761
13.

Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial.

Raghu G, Brown KK, Collard HR, Cottin V, Gibson KF, Kaner RJ, Lederer DJ, Martinez FJ, Noble PW, Song JW, Wells AU, Whelan TP, Wuyts W, Moreau E, Patterson SD, Smith V, Bayly S, Chien JW, Gong Q, Zhang JJ, O'Riordan TG.

Lancet Respir Med. 2017 Jan;5(1):22-32. doi: 10.1016/S2213-2600(16)30421-0. Epub 2016 Dec 7.

PMID:
27939076
14.

Subclinical venous access infection and clinical worsening in pulmonary arterial hypertension.

Chebib N, Mornex JF, Cottin V.

J Heart Lung Transplant. 2017 Mar;36(3):369-370. doi: 10.1016/j.healun.2016.10.012. Epub 2016 Oct 21. No abstract available.

PMID:
27914895
15.

Familial vs. sporadic sarcoidosis: BTNL2 polymorphisms, clinical presentations, and outcomes in a French cohort.

Pacheco Y, Calender A, Israël-Biet D, Roy P, Lebecque S, Cottin V, Bouvry D, Nunes H, Sève P, Pérard L, Devouassoux G, Freymond N, Khouatra C, Wallaert B, Lamy R, Elsensohn MH, Bardel C, Valeyre D; GSF group..

Orphanet J Rare Dis. 2016 Dec 3;11(1):165.

16.

Idiopathic interstitial pneumonia-associated pulmonary hypertension: A target for therapy?

Nathan SD, Behr J, Cottin V, Collard HR, Hoeper MM, Martinez FJ, Wells AU.

Respir Med. 2017 Jan;122 Suppl 1:S10-S13. doi: 10.1016/j.rmed.2016.11.003. Epub 2016 Nov 5.

PMID:
27884593
17.

The Clinical Relevance of Antifibrillarin (anti-U3-RNP) Autoantibodies in Systemic Sclerosis.

Tall F, Dechomet M, Riviere S, Cottin V, Ballot E, Tiev KP, Montin R, Morin C, Chantran Y, Grange C, Jullien D, Ninet J, Chretien P, Cabane J, Fabien N, Johanet C.

Scand J Immunol. 2017 Jan;85(1):73-79. doi: 10.1111/sji.12510.

PMID:
27864990
18.

Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis.

Borie R, Tabèze L, Thabut G, Nunes H, Cottin V, Marchand-Adam S, Prevot G, Tazi A, Cadranel J, Mal H, Wemeau-Stervinou L, Bergeron Lafaurie A, Israel-Biet D, Picard C, Reynaud Gaubert M, Jouneau S, Naccache JM, Mankikian J, Ménard C, Cordier JF, Valeyre D, Reocreux M, Grandchamp B, Revy P, Kannengiesser C, Crestani B.

Eur Respir J. 2016 Dec;48(6):1721-1731. doi: 10.1183/13993003.02115-2015. Epub 2016 Nov 11.

PMID:
27836952
19.

Therapeutic benefit of ivacaftor in late cystic fibrosis caused by homozygous IVS8-5T CFTR polymorphism.

Magne F, Durupt S, Nove-Josserand R, Bey-Omar F, Laoust L, Cottin V, Durieu I, Reynaud Q.

J Cyst Fibros. 2017 Jan;16(1):89-90. doi: 10.1016/j.jcf.2016.10.008. Epub 2016 Oct 31. No abstract available.

PMID:
27810230
20.

Lung biopsy in interstitial lung disease: balancing the risk of surgery and diagnostic uncertainty.

Cottin V.

Eur Respir J. 2016 Nov;48(5):1274-1277. doi: 10.1183/13993003.01633-2016. No abstract available. Erratum in: Eur Respir J. 2016 Dec;48(6):1819.

PMID:
27799381

Supplemental Content

Loading ...
Support Center